SALVATORE, Giuliana
 Distribuzione geografica
Continente #
NA - Nord America 7.999
EU - Europa 4.173
AS - Asia 2.043
SA - Sud America 356
Continente sconosciuto - Info sul continente non disponibili 252
AF - Africa 44
OC - Oceania 4
Totale 14.871
Nazione #
US - Stati Uniti d'America 7.923
RU - Federazione Russa 1.555
UA - Ucraina 676
SG - Singapore 621
VN - Vietnam 592
CN - Cina 582
IT - Italia 471
SE - Svezia 345
GB - Regno Unito 314
DE - Germania 304
BR - Brasile 264
FR - Francia 175
FI - Finlandia 101
NL - Olanda 84
HK - Hong Kong 45
CA - Canada 38
IN - India 33
PL - Polonia 31
AR - Argentina 29
BD - Bangladesh 22
AT - Austria 20
PK - Pakistan 20
TR - Turchia 20
EU - Europa 19
ZA - Sudafrica 19
CO - Colombia 18
MX - Messico 16
BE - Belgio 15
EC - Ecuador 15
IQ - Iraq 15
IE - Irlanda 14
CZ - Repubblica Ceca 13
JP - Giappone 13
MY - Malesia 11
LV - Lettonia 9
PH - Filippine 9
VE - Venezuela 9
PY - Paraguay 8
ES - Italia 7
MA - Marocco 7
PE - Perù 7
SA - Arabia Saudita 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
IL - Israele 6
KR - Corea 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
NI - Nicaragua 4
RO - Romania 4
TN - Tunisia 4
BY - Bielorussia 3
BZ - Belize 3
DZ - Algeria 3
EG - Egitto 3
ID - Indonesia 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MK - Macedonia 3
SN - Senegal 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
LK - Sri Lanka 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BT - Bhutan 1
DO - Repubblica Dominicana 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KN - Saint Kitts e Nevis 1
LT - Lituania 1
MC - Monaco 1
MM - Myanmar 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
Totale 14.636
Città #
Fairfield 965
Woodbridge 707
Houston 587
Ashburn 537
Chandler 454
Ann Arbor 444
San Jose 422
Seattle 395
Wilmington 382
Dong Ket 377
Cambridge 327
Dallas 298
Singapore 281
Moscow 272
The Dalles 257
Nyköping 220
Dearborn 207
Jacksonville 178
Boardman 157
Southend 146
Naples 134
Beijing 113
Ho Chi Minh City 93
Council Bluffs 82
Napoli 76
Princeton 70
Lawrence 64
Groningen 63
New York 60
Grafing 59
Yubileyny 58
Ogden 52
Hanoi 44
Munich 43
Helsinki 42
Shanghai 42
Los Angeles 41
Hong Kong 36
San Diego 36
Phoenix 34
Milan 30
Santa Clara 30
Des Moines 27
Düsseldorf 26
Hutchinson 24
Formia 23
São Paulo 23
Frankfurt am Main 20
London 20
Chicago 18
Jinan 18
Norwalk 17
Rome 17
Lauterbourg 15
Warsaw 15
Brussels 14
Hefei 14
Kunming 13
Orem 13
Tokyo 13
Boydton 12
Da Nang 12
Vienna 12
Atlanta 11
Auburn Hills 11
Boston 11
Dublin 11
Kraków 11
Amsterdam 10
Nanjing 10
Medellín 9
Montreal 9
Redmond 9
Riga 9
Afragola 8
Bremen 8
Buenos Aires 8
Edinburgh 8
Haiphong 8
Lahore 8
Nocera Inferiore 8
Redwood City 8
Brno 7
Guayaquil 7
Rio de Janeiro 7
Tashkent 7
Blue Springs 6
Charlotte 6
Chennai 6
Mercato San Severino 6
Miami 6
Nanchang 6
Nuremberg 6
Philadelphia 6
Shenyang 6
Stockholm 6
Tampa 6
Turku 6
Baku 5
Brooklyn 5
Totale 9.566
Nome #
Extracellular superoxide dismutase is a thyroid differentiation marker down-regulated in cancer 351
TWIST1/miR-584/TUSC2 pathway induces resistance to apoptosis in thyroid cancer cells 306
Unveiling the miRNAs responsive to physical activity/exercise training in cancer: A systematic review 306
A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma 287
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer 281
Junctional adhesion molecule-A is down-regulated in anaplastic thyroid carcinomas and reduces cancer cell aggressiveness by modulating p53 and GSK3 α/β pathways 281
Long-term recreational football training and health in aging 274
Anterior gradient protein 2 promotes survival, migration and invasion of papillary thyroid carcinoma cells 263
Anaplastic Thyroid Carcinoma: Molecular Tools for Diagnosis and Therapy 255
Cytostatic Activity of Adenosine Triphosphate-Competitive Kinase Inhibitors in BRAF Mutant Thyroid Carcinoma Cells 247
BAY 43-9006 inhibition of oncogenic RET mutants. 246
RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma 245
Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. 243
A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. 243
Identification of polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma 242
miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA 240
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes 232
Multimodal imaging for a theranostic approach in a murine model of B-cell lymphoma with engineered nanoparticles 231
Analysis of BRAF Point Mutation and RET/PTC Rearrangement Refines the Fine-Needle Aspiration Diagnosis of Papillary Thyroid Carcinoma 229
Different mutations of the RET gene cause different human tumoral diseases 225
The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma 225
BRAF Is a Therapeutic Target in Aggressive Thyroid Carcinoma 225
Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer 225
Glial cell line-derived neurotrophic factor induces proliferative inhibition of NT2/D1 cells through RET-mediated up-regulation of the cyclin-dependent kinase inhibitor p27(kip1) 223
Identification of targets of twist1 transcription factor in thyroid cancer cells. 220
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas 219
BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas 216
Induction of caspase-dependent programmed cell death in B-cell chronic lymphocytic leukemia by anti-CD22 immunotoxins 215
Receptor tyrosine kinase inhibitors in thyroid cancer 214
High-Frequency Ultrasound-Guided Injection for the Generation of a Novel Orthotopic Mouse Model of Human Thyroid Carcinoma 212
DNA immunization followed by a single boost with cells: a protein-free immunization protocol for production of monoclonal antibodies against the native form of membrane proteins 210
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells 207
Dissecting the molecular pathways involved in the effects of physical activity on breast cancers cells: A narrative review 207
Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase 205
Potent mitogenicity of the RET/PTC3 oncogene correlates with its prevalence in tall-cell variant of papillary thyroid carcinoma 203
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potential 200
FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma. 199
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness 198
Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia 196
Tyrosines 1015 and 1062 are in vivo autophosphorylation sites in ret and ret-derived oncoproteins 190
PATE, a gene expressed in prostate cancer, normal prostate, and testis, identified by a functional genomic approach 185
Morphological ultrasound microimaging of thyroid in living mice 185
Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice. 184
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease 183
MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer 182
Identification of a novel subtype of H4-RET rearrangement in a thyroid papillary carcinoma and lymph node metastasis 182
High Frequency Ultrasound for the development of an Orthotopic mouse model of Human Follicular Thyroid Carcinoma 181
Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas 179
Presence of BRAF V600E in Very Early Stages of Papillary Thyroid Carcinoma 177
Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas 174
TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype 172
Pros and cons of cellular studies in developing new drugs for thyroid cancers 167
Molecular biology of the MEN2 gene 166
Molecular profile of hyalinizing trabecular tumors of the thyroid: high prevalence of RET/PTC rearrangements and absence of B-raf and N-ras point mutations 165
Monitoring training in non-professional soccer players by coupling SSGs and GPS technology: effects of pitch size and players role 165
miR-622 Is a Novel Potential Biomarker of Breast Carcinoma and Impairs Motility of Breast Cancer Cells Through Targeting NUAK1 Kinase 163
Regular football training down-regulates miR-1303 muscle expression in veterans 161
Mitogenic effects of the up-regulation of MiniChromosome Maintenance proteins (MCM) in anaplastic thyroid carcinoma 160
Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display 158
Frequent mutation of PIK3CA in Anaplastic Thyroid Cancer 156
Adiponectin and leptin exert antagonizing effects on proliferation and motility of papillary thyroid cancer cell lines 155
The different RET-activating capability of mutations of cysteine 620 or cysteine 634 correlates with the multiple endocrine neoplasia type 2 disease phenotype 151
RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotypes 146
Evolution of intra-tumoral heterogeneity across different pathological stages in papillary thyroid carcinoma 142
Effects of Annurca Flesh Apple Polyphenols in Human Thyroid Cancer Cell Lines 139
High prevalence of RET/PTC rearrangements in Ukrainian and Belarussia post-Chernobyl thyroid papillary carcinomas: a strong correlation between RET/PTC3 and the solid-follicular variant 138
miR-331-5p Affects Motility of Thyroid Cancer Cell Lines and Regulates BID Expression 133
The TUSC2 Tumour Suppressor Inhibits the Malignant Phenotype of Human Thyroid Cancer Cells via SMAC/DIABLO Protein 133
Preclinical Imaging Evaluation of miRNAs' Delivery and Effects in Breast Cancer Mouse Models: A Systematic Review 112
Insight into the Role of the miR-584 Family in Human Cancers 104
Exercise’s impact on lung cancer molecular mechanisms: a current overview 98
The lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and it is necessary for leukemic cell growth 93
Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype 91
Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting 89
Association of radiomic features with genomic signatures in thyroid cancer: a systematic review. 84
Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells 76
Aberrant Expression of Non-Coding RNAs in Pediatric T Acute Lymphoblastic Leukemia and Their Potential Application as Biomarkers 75
Lipid-Polymer Nanoparticles (LiPoNs) Mediated Codelivery of AntimiR-21 and Gadolinium Chelate in Triple Negative Breast Cancer Theranostics 31
Totale 14.871
Categoria #
all - tutte 60.250
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.250


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022564 0 0 0 199 16 24 108 53 71 41 47 5
2022/20231.485 144 91 140 172 229 216 56 161 159 44 55 18
2023/2024390 29 29 34 23 11 48 19 14 79 23 26 55
2024/20252.981 60 230 36 60 34 293 624 987 148 114 306 89
2025/20262.489 166 294 212 137 162 63 427 316 321 233 95 63
2026/2027400 42 36 263 59 0 0 0 0 0 0 0 0
Totale 14.871